- UPDATE 2-U.S. corn stockpile smaller than expected, prices jump Fri, Jan 11 2013
- Monsanto sees range of new products, raises profit outlook Tue, Jan 8 2013
- Farmers hustle to avoid “fiscal cliff” blowback Fri, Dec 21 2012
Fri Jan 18, 2013 1:49pm EST
* Dow AgroSciences awaiting regulatory approval
* Says ramping up seed production, hopeful for 2014 sales
* Critics oppose use of Enlist herbicide and Enlist crops
By Carey Gillam
Jan 18 (Reuters) – A controversial new biotech corn developed by Dow AgroSciences, a unit of Dow Chemical,, will be delayed at least another year as the company awaits regulatory approval amid opposition from farmers, consumers and public health officials.
Dow AgroSciences officials said Friday that they now expect the first sales of Enlist for planting in 2014. Previously officials had set the 2013 planting season as a target, but U.S. farmers are already buying seed for planting this spring, and Dow has yet to secure U.S. approval for Enlist.
Dow wants to roll out Enlist corn, and then soybeans and cotton to be used in combination with its new Enlist herbicide that combines the weed-killers 2,4-D and glyphosate. The Enlist crops are genetically altered to tolerate treatments of the Enlist herbicide mixture. The hope is that Enlist will wipe out an explosion of crop-choking weeds that have become resistant to glyphosate alone.
Opponents have bombarded Dow and U.S. regulators with an array of concerns about Enlist, which is intended to replace Monsanto Co.’s successful Roundup Ready system. Genetically altered Roundup Ready corn and soybeans now dominate the U.S. corn and soybean market.
But as Roundup Ready crops have gained popularity, millions of acres of weeds have developed resistance to Roundup herbicide, causing farmers to use higher quantities of Roundup and other herbicides to try to beat back the weeds.